Status:
COMPLETED
Thoracic Fluid Content During Hypervolemic Hemodilution
Lead Sponsor:
Cairo University
Conditions:
Pulmonary Edema
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Thoracic fluid content (TFC) is one of the many variables measured by the ICON electrical cardiometry (EC) device (Osypka Medical). The ICON device is often called "thoracic electrical bio-impedance" ...
Eligibility Criteria
Inclusion
- female
- 18-45 years old
- ASA I-II
Exclusion
- younger than 18 years,
- ASA \> or = III
- patients with respiratory, cardiac disease, cardiac arrhythmias,
- body mass index above 40 kg/m2
- renal insufficiency,
- sepsis,
- hypovolemia denoted by PPV \> 13 detected after start of mechanical ventilation,
- preoperative baseline LUS score 10 or more,
- TFC \> or = 26 k ohm-1,
- patients with neck or chest lesions that impair the application of cardiometry electrodes
Key Trial Info
Start Date :
December 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 2 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04689516
Start Date
December 24 2020
End Date
January 2 2022
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University hospitals
Cairo, Manial, Egypt, 12511